Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout 

The non-opioid pain space is attracting increasing attention as experts sound the alarm on dependency issues linked to long-term opioid-based pain management.

Latest news

Roche’s Tecentriq snags FDA label expansion in type of colon cancer 

Tecentriq is now the first immunotherapy indicated for dMMR colon cancer treatment specifically, which is often linked to a higher risk of progression after surgery.

Biohaven partners with Ono in $100m IgG degrader deal

The transaction grants Ono exclusive rights for candidates BHV-1300, BHV-1310, and BHV-1320 across Taiwan, South Korea, and Japan.

Bio-Techne opens GMP small molecule facility in Bristol, UK

The purpose-built site is fully operational and produces materials to support developers working on cell therapies globally.

Change lifestyle before giving children weight loss medication, WHO says

In its first global guidelines for child and adolescent obesity, the WHO says diet, exercise, and behavioural changes should be the first port of call.

FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer

Regulatory clearance was based on findings from the double-blind, placebo-controlled Phase III HER2CLIMB-05 trial.